Eczema Treatment Cream Recalled Due to Serious Infection Risk

Want the full story?
Read the complete article at KTSM
AI Summary
A recall has been issued for the Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, marketed as MG217, after contamination with Staphylococcus aureus was detected. This bacteria poses a significant risk of life-threatening infections, prompting the Food and Drug Administration (FDA) to take action. Consumers using this product should be aware of the potential health hazards associated with it. The recall affects a specific batch of the cream, and users are advised to discontinue its use immediately and consult healthcare professionals if they experience any adverse effects.
Key Details: • Discontinue use of MG217 Eczema Cream immediately. • Consult a healthcare provider if experiencing any symptoms of infection. • Check product packaging for batch numbers related to the recall.